ÂÜÀòÂÒÂ×

Michelle Johnson, CPA, has a diverse work experience spanning multiple industries. Michelle currently holds the position of Vice President, Head of Finance at Rapport Therapeutics, starting in May 2023. Prior to this role, Michelle worked at Affinivax Inc. as Senior Director, Head of FP&A from July 2021 to April 2023. Michelle also held various roles in Agios Pharmaceuticals, including Senior Director, Head of FP&A from March 2021 to July 2021 and Director, FP&A from October 2019 to March 2021. Michelle started their career in Biogen, where they served as Associate Director, R&D Finance, Senior Manager, R&D Finance, Manager, R&D Finance, and Senior Analyst, R&D Finance from April 2013 to September 2017. Before entering the pharmaceutical industry, Michelle gained experience in finance and accounting at Dell, where they held roles such as Treasury - Senior Finance Advisor, Services Revenue Accounting - Senior Accounting Advisor, Corporate Finance - Finance Advisor, and Financial Reporting - Senior Accountant from August 2005 to April 2013. Michelle began their career as a Senior Auditor and Staff Accountant at Brown Graham & Company PC from December 2003 to August 2005. Michelle's earliest work experience was as a Staff Accountant at Austin Health Resources Inc. & Community Choice, Inc. from June 2000 to December 2003.

Michelle Johnson, CPA completed their education at Texas State University. From 2001 to 2003, they obtained a Bachelor of Business Administration (BBA) degree with a concentration in Accounting. Additionally, during the same time period, they also earned another BBA degree with a focus on Finance. Later, from 2007 to 2009, Michelle pursued their Master of Business Administration (MBA) degree with a specialization in Business.